Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glutathione S-transferase kappa 1 (GSTK1) is an enzyme belonging to the kappa class of the glutathione S-transferase superfamily, uniquely targeted to mitochondria and peroxisomes[1][2][6]. It catalyzes the conjugation of glutathione to hydrophobic endogenous and exogenous substrates, facilitating cellular detoxification and the removal of potentially harmful compounds[1][4]. GSTK1 displays structural similarities to bacterial isomerases rather than to canonical cytosolic GSTs, and its activity profile suggests participation in specific non-canonical reactions or redox regulation[1][3]. Beyond detoxification, GSTK1 may function as a chaperone in adiponectin biosynthesis, thus influencing metabolic syndromes such as obesity and diabetes[2]. Mouse models lacking GSTK1 reveal subclinical glomerular disease and altered kidney structure, highlighting its physiological significance[6]. The protein is highly expressed in heart, kidney, liver, and skeletal muscle, and polymorphisms in its regulatory regions connect it to insulin secretion and metabolic disease pathology[2][6][4].
Drugs or agents targeting GSTK1 (or GSTs in general) typically act by: - Inhibiting or modulating enzyme activity for detoxification - Altering glutathione conjugation reactions to modify cellular response to oxidative stress - Regulating metabolic or redox functions (speculative for GSTK1)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutathione S-transferase kappa 1 (GSTK1).